Balchem Corporation (BCPC)
Basic Materials
Specialty Chemicals
167.60 $
Closing price · As of: 31. Jul 2026
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Balchem Corporation.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 8 of our scanner strategies — each hit links to the scanner.
Quality & Balance Sheet
Breakout & Setup
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Basics
Market Cap
The value of the entire company on the market: share price times total shares outstanding.
5.4$B
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
32Mio.
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
99.4%
Beta
Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market.
0.8
Performance
Perf. 1M
Price performance over the last month.
5.60%
Perf. 3M
Price performance over the last 3 months.
1.40%
Perf. 6M
Price performance over the last 6 months.
7.80%
YTD Performance (%)
Price performance since the start of the year (Year to Date).
8.30%
52-Week-High Distance
How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high.
-8.0%
Valuation
P/E
Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E.
34.4
Forward P/E
P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future.
31.1
PEG
P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey.
3.9
P/B
Price-to-book ratio: market value relative to book equity.
4.2
P/S
Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable.
4.9
EV/EBITDA
Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero.
21.3
Price/FCF
Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up.
29.5
Profitability
Gross Margin
Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power.
36.3%
EBIT Margin
EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes.
20.9%
Net Margin
Net margin: what's left of sales as profit after ALL costs, interest, and taxes.
15.0%
Return on Equity
Return on equity: how much profit does the company generate per year on shareholders' equity?
12.7%
Return on Assets
Return on assets: how much profit the company generates from its total assets (equity and debt combined).
8.1%
Balance Sheet & Safety
Equity Ratio
Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet.
75.9%
Debt/Equity
Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity.
0.4
fortress balance sheet
Altman Z″
Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks.
10.55
Piotroski
Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag.
7 out of 9
Growth
Sales Growth Last Quarter
Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY).
8.10%
EPS Growth Last Quarter
Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY).
10.60%
Sales Growth (Year)
Sales growth in the last fiscal year versus the year before.
8.75%
Forward Sales Growth
Sales growth analysts expect over the next 12 months — an estimate, not a guarantee.
5.29%
Forward EPS Growth
Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee.
7.50%
Dividend
Dividend Yield
Annual dividend divided by the current price: what percentage of your investment comes back as a payout each year.
0.57%
Dividend Per Share (TTM)
Sum of dividends paid per share over the last 12 months.
0.96$
Payout Ratio
Share of profit paid out as dividends. Over 100% means the company is paying out more than it earns — not sustainable long-term.
18.3%
Years Without a Cut
How many years in a row the dividend hasn't been cut — a measure of reliability.
1Years
Increase Streak
How many years in a row the dividend has been raised — the gold standard for dividend payers.
1Years
Quality & Screener
Stage
Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line.
2
RS Rating
Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks.
40
EPS Rating
Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth.
59
Piotroski
Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag.
7 out of 9
Fundamental Rating
Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below.
B (55 out of 100)
fortress balance sheet
Altman Z″
Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks.
10.55
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 1.03 | 25.70 | 240 | 4.90 | 14.00 | 52 | 40 |
| 2025: Q1 | 1.13 | 27.10 | 251 | 4.50 | 14.80 | 37 | 31 |
| 2025: Q2 | 1.17 | 19.00 | 256 | 9.10 | 15.00 | 47 | 40 |
| 2025: Q3 | 1.23 | 19.40 | 268 | 11.50 | 15.10 | 66 | 51 |
| 2025: Q4 | 1.21 | 17.60 | 264 | 9.80 | 14.90 | 67 | 51 |
| 2026: Q1 | 1.25 | 10.50 | 271 | 8.10 | 14.90 | 40 | 34 |
| 2026: Q2 | 1.39 | 18.80 | 284 | 11.20 | 15.70 | 47 | 47 |
What Do These Terms Mean?
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
About the Company
Balchem Corporation entwickelt, fertigt und vertreibt Spezialleistungszutaten und -produkte für die Märkte Ernährung, Lebensmittel, Pharma, Tiergesundheit, Medizinproduktsterilisation, Pflanzenernährung und Industrie weltweit. Sie ist in drei Segmenten tätig: Human Nutritio…
| Employees | 1,368 |
|---|---|
| Headquarters | Montvale, NJ |
| Website | balchem.com |
| IPO Date | 3. Jun 1986 |
| Next Earnings | 30. Jul 2026 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Theodore Lee Harris | CEO, President & Chairman | 1965 |
| Carl Martin Bengtsson | Executive VP, CFO, Treasurer and GM of Animal Nutrition & Health | 1977 |
| Hatsuki Miyata J.D. | Executive VP, Chief Legal Officer & Secretary | 1976 |
| M. Brent Tignor | Senior VP & Chief Human Resources Officer | 1978 |
| Frederic Boned | Senior VP, Head of Digital Transformation & AI and GM of Human Nutrition & Health | 1979 |
| Erin L. Gilson | VP & Chief Accounting Officer | – |
| Martin Luther Reid | Senior VP & Chief Supply Chain Officer | 1967 |
| Job L. van Gunsteren | Senior VP & GM of Specialty Products | 1977 |
| George Graham | Senior VP and Chief R&D Officer | 1970 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.